Infertility treatments and risk of breast benign diseases: a case‒control study.
Assisted reproductive techniques
Breast benign diseases
Infertility treatment
Ovarian-stimulating hormones
Ovulation induction
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
01 Nov 2024
01 Nov 2024
Historique:
received:
18
11
2023
accepted:
24
10
2024
medline:
1
11
2024
pubmed:
1
11
2024
entrez:
1
11
2024
Statut:
epublish
Résumé
Theoretically, endocrine fluctuations occurring during infertility treatments, including ovulation induction (OI) and assisted reproductive techniques (ART), could be associated with an increased risk of benign breast diseases (BBDs). To date, no studies have been conducted on this association. Therefore, the present study investigated the association between different types of infertility treatments and BBDs. This case‒control study was conducted in Arash Women's Hospital, Tehran, Iran. The case group included infertile women diagnosed with BBDs without atypia, and the control group included infertile women without breast disease. Breast imaging studies (mammography/ultrasound) were performed for BBD screening, and the diagnosis was confirmed by histopathological examination. Study variables were collected retrospectively from medical records, hospital databases, and questionnaires. Finally, 154 infertile women, including 50 cases (BBDs) and 104 controls (no BBDs), were compared. Our data showed that 66% of cases and 61.4% of controls had undergone at least one course of infertility treatment. There was no association between BBD risk and previous infertility treatments (OR = 1.21; 95% CI = 0.59-2.46), ART (OR = 1.14; 95% CI = 0.90-1.44), or OI cycles (OR = 1.13; 95% CI = 0.98-1.32). Stratification by confounding variables did not change these results. It seems that there is no association between BBDs in infertile women and the type, duration, or number of prior infertility treatments; however, considering the small sample size of the study, the clinical significance of this finding should not be neglected. Therefore, we consider it essential to carry out more extensive, detailed, and prospective studies to distinguish the association of BBDs with different infertility treatments and medications.
Sections du résumé
BACKGROUND
BACKGROUND
Theoretically, endocrine fluctuations occurring during infertility treatments, including ovulation induction (OI) and assisted reproductive techniques (ART), could be associated with an increased risk of benign breast diseases (BBDs). To date, no studies have been conducted on this association. Therefore, the present study investigated the association between different types of infertility treatments and BBDs.
METHODS
METHODS
This case‒control study was conducted in Arash Women's Hospital, Tehran, Iran. The case group included infertile women diagnosed with BBDs without atypia, and the control group included infertile women without breast disease. Breast imaging studies (mammography/ultrasound) were performed for BBD screening, and the diagnosis was confirmed by histopathological examination. Study variables were collected retrospectively from medical records, hospital databases, and questionnaires.
RESULTS
RESULTS
Finally, 154 infertile women, including 50 cases (BBDs) and 104 controls (no BBDs), were compared. Our data showed that 66% of cases and 61.4% of controls had undergone at least one course of infertility treatment. There was no association between BBD risk and previous infertility treatments (OR = 1.21; 95% CI = 0.59-2.46), ART (OR = 1.14; 95% CI = 0.90-1.44), or OI cycles (OR = 1.13; 95% CI = 0.98-1.32). Stratification by confounding variables did not change these results.
CONCLUSIONS
CONCLUSIONS
It seems that there is no association between BBDs in infertile women and the type, duration, or number of prior infertility treatments; however, considering the small sample size of the study, the clinical significance of this finding should not be neglected. Therefore, we consider it essential to carry out more extensive, detailed, and prospective studies to distinguish the association of BBDs with different infertility treatments and medications.
Identifiants
pubmed: 39482608
doi: 10.1186/s12905-024-03429-w
pii: 10.1186/s12905-024-03429-w
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
584Informations de copyright
© 2024. The Author(s).
Références
Sangma MMB, Panda K, Dasiah S. A clinico-pathological study on benign breast diseases. J Clin Diagn Res. 2013;7.
El-Wakeel H, Umpleby HC. Systematic review of fibroadenoma as a risk factor for breast cancer. Breast. 2003;12.
DL WDD. P. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 312:146–51.
Figueroa JD, Gierach GL, Duggan MA, Fan S, Pfeiffer RM, Wang Y et al. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease. Breast Cancer Res. 2021;23.
Kuang K, Wilson SR. A Meta-Analysis of Uncertainty and Information Management in Illness Contexts. J Communication. 2017;67.
Hayes Balmadrid MA, Shelby RA, Wren AA, Miller LS, Yoon SC, Baker JA et al. Anxiety prior to breast biopsy: Relationships with length of time from breast biopsy recommendation to biopsy procedure and psychosocial factors. J Health Psychol. 2017;22.
Soini I, Aine R, Lauslahti K, Hakama M. Independent risk factors of benign and malignant breast lesions. Am J Epidemiol. 1981;114:507–14.
doi: 10.1093/oxfordjournals.aje.a113216
pubmed: 7304581
Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, et al. Benign Breast Disease and the Risk of Breast Cancer. N Engl J Med. 2005;353:229–37.
doi: 10.1056/NEJMoa044383
pubmed: 16034008
Momenimovahed Z. and HS-BCT, 2019 undefined. Epidemiological characteristics of and risk factors for breast cancer in the world. Taylor & Francis. 2019;11:151–64.
Beral V, Bull D, Doll R, Peto R, … GR-, 2004 undefined. Collaborative group on hormonal factors in breast cancer: breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including. cris.maastrichtuniversity.nl.
Zreik T, Mazloom A, Chen Y, … MV-B cancer research, 2010 undefined. Fertility drugs and the risk of breast cancer: a meta-analysis and review. Springer.
Beebeejaun Y, Athithan A, Copeland T, … MK-F and, 2021 undefined. Risk of breast cancer in women treated with ovarian stimulation drugs for infertility: a systematic review and meta-analysis. Elsevier.
Sergentanis T, … AD-H reproduction, 2014 undefined. IVF and breast cancer: a systematic review and meta-analysis. academic.oup.com.
Gennari A, Costa M, Puntoni M, Paleari L, De Censi A, Sormani MP, et al. Breast cancer incidence after hormonal treatments for infertility: systematic review and meta-analysis of population-based studies. Breast Cancer Res Treat. 2015;150:405–13.
doi: 10.1007/s10549-015-3328-0
pubmed: 25744295
Farland LV, Wang S, Rich-Edwards JW, Gaskins AJ, Chavarro JE, Wang YX et al. History of infertility and risk of breast cancer: a prospective cohort study. Breast Cancer Res Treat. 2023;199.
Wang S, Gaskins AJ, Farland LV, Zhang D, Birmann BM, Rich-Edwards JW et al. A prospective cohort study of infertility and cancer incidence. Fertil Steril. 2023;120.
Penzias A, Bendikson K, Falcone T, Hansen K, Hill M, Jindal S, et al. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020;113:305–22.
doi: 10.1016/j.fertnstert.2019.10.014
Catsburg C, Gunter MJ, Chen C, Cote ML, Kabat GC, Nassir R, et al. Insulin, estrogen, inflammatory markers, and risk of benign proliferative breast disease. Cancer Res. 2014;74:3248–58.
doi: 10.1158/0008-5472.CAN-13-3514
pubmed: 24755474
Johansson A, Christakou AE, Iftimi A, Eriksson M, Tapia J, Skoog L, et al. Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden. JAMA Netw Open. 2021;4:e2114716–2114716.
doi: 10.1001/jamanetworkopen.2021.14716
pubmed: 34170304
pmcid: 8233703
Andarieh M, Delavar M, … DM-J of C, 2019 undefined. Infertility as a risk factor for breast cancer: Results from a hospital-based case–control study. journals.lww.com.
Stentz NC, Koelper N, Barnhart KT, Sammel MD, Senapati S. Infertility and mortality. Am J Obstet Gynecol. 2020;222:251.e1-251.e10.
Lundberg FE, Iliadou AN, Rodriguez-Wallberg K, Gemzell-Danielsson K, Johansson ALV. The risk of breast and gynecological cancer in women with a diagnosis of infertility: a nationwide population-based study. Eur J Epidemiol. 2019;34:499–507.
doi: 10.1007/s10654-018-0474-9
pubmed: 30623293
pmcid: 6456460
Colditz G. epidemiology BR-A journal of, 2000 undefined. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health Study. academic.oup.com.
Goehring C, reviews AM-E. 1997 undefined. Epidemiology of benign breast disease, with special attention to histologic types. doc.rero.ch
Wang DY, Fentiman IS. Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat. 1985;6:5–36.
doi: 10.1007/BF01806008
pubmed: 3902125
Pasqualini JR, Cortes-Prieto J, Chetrite G, Talbi M, Ruiz A. Concentrations of estrone, estradiol and their sulfates, and evaluation of sulfatase and aromatase activities in patients with breast fibroadenoma. Wiley Online Libr. 1997;70:639–43.
Malet C, Gompel A, Yaneva H, Cren H, Fidji N, Mowszowicz I, et al. Estradiol and Progesterone Receptors in Cultured Normal Human Breast Epithelial Cells and Fibroblasts: Immunocytochemical Studies. J Clin Endocrinol Metab. 1991;73:8–17.
doi: 10.1210/jcem-73-1-8
pubmed: 2045475